Evaluation of Radiographic, Neuropathological, and Demographic Findings in Children Aged 1 To 18 Years with Brain Tumor
Novelty in Biomedicine,
Vol. 12 No. 2 (2024),
29 Ordibehesht 2024
,
Page 55- 59
https://doi.org/10.22037/nbm.v12i2.44032
Abstract
Background: Brain tumors in children can involve different parts of the brain and cause high mortality. These tumors have different types, and they cause different conflicts and complications. So far, limited studies have been conducted in Iran on children's brain tumors. This study aimed to evaluate radiographic, neuropathological, and demographic findings in children aged 1 to 18 years with brain tumors.
Materials and Methods: In this descriptive study, which was conducted for children aged 1 to 18 years with brain tumors admitted to the children's ward of Shohada Hospital (Iran-Tehran) in 2012-2018, 64 children were evaluated. Patient information was extracted from patients' files, including basic data radiological and clinical findings. A significance level was considered less than 0.05.
Results: Twenty-six patients (40.6%) were girls, and 38 (59.4%) were boys. 96.9% of the children were term, and the mortality rate was 40.6%. 57.8% were diagnosed in less than one month from the onset of symptoms. 47.6% of patients had a positive family history, and none of them had a history of brain infection. The most common clinical complaint was N/V. The most common location of the tumor was the fourth ventricle (31.3%), and acute hydrocephalus was also seen in 19 patients (29.7%). The most common tumor was medulloblastoma (93.8%), and the most common stage was grade 4 (98.4%). Desmoplastic medulloblastoma was the most common form of medulloblastoma. 9.4% of patients were positive for tumor marker P53. None of the patients were positive for Beta-Catenin.
Conclusion: The findings have shown that being a boy, involvement of the fourth ventricle and medulloblastoma are the most common characteristics of brain tumor involvement in Iranian children.
- Brain tumor
- Pediatric
- Medulloblastoma
How to Cite
References
Nakamura H, Makino K, Yano S, Kuratsu J-i, Group KBTR. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto prefecture in southern Japan—20-year study. International journal of clinical oncology. 2011;16:314-21.
Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. Journal of the national cancer institute. 2011;103(9):714-36.
Cowppli-Bony A, Bouvier G, Rué M, et al. Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes & Control. 2011;22:697-714.
Bishop AJ, McDonald MW, Chang AL, Esiashvili N. Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) Data. International Journal of Radiation Oncology* Biology* Physics. 2012;82(1):341-7.
Sadeghmousavi S, Rezaei N, Hanaei S. Nutrition and Diet: A Double-Edged Sword in Development and Treatment of Brain Tumors. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1: Neuroimmunology and Neurogenetics: Springer; 2023:153-80.
Von Behren J, Spector LG, Mueller BA, et al. Birth order and risk of childhood cancer: a pooled analysis from five US States. International Journal of Cancer. 2011;128(11):2709-16.
Farwell J, Flannery JT. Cancer in relatives of children with central-nervous-system neoplasms. New England Journal of Medicine. 1984;311(12):749-53.
Pollack IF. Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research. Journal of child neurology. 2008;23(10):1179-85.
Levine AJ. The many faces of p53: something for everyone. Journal of molecular cell biology. 2019;11(7):524-30.
Orr BA, Clay MR, Pinto EM, Kesserwan C. An update on the central nervous system manifestations of Li–Fraumeni syndrome. Acta neuropathologica. 2020;139:669-87.
Zhang Y, Dube C, Gibert Jr M, et al. The p53 pathway in glioblastoma. Cancers. 2018;10(9):297.
Bjørge T, Sørensen HT, Grotmol T, et al. Fetal growth and childhood cancer: a population-based study. Pediatrics. 2013;132(5):1265-75.
Zechner D, Fujita Y, Hülsken J, et al. β-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Developmental biology. 2003;258(2):406-18.
Manfreda L, Rampazzo E, Persano L. Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target. Biology. 2023;12(5):729.
Quach P, El Sherif R, Gomes J, Krewksi D. A systematic review of the risk factors associated with the onset and progression of primary brain tumours. Neurotoxicology. 2017;61:214-32.
Shah HC, Ubhale BP, Shah JK. Demographic and histopathologic profile of pediatric brain tumors: A hospital-based study. South Asian Journal of Cancer. 2015;4(03):146-8.
Ogun GO, Adeleye AO, Babatunde TO, et al. Central nervous system tumours in children in Ibadan, Nigeria: a histopathologic study. Pan African Medical Journal. 2016;24(1).
Jaiswal J, Shastry AH, Ramesh A, Chickabasaviah YT, Arimappamagan A, Santosh V. Spectrum of primary intracranial tumors at a tertiary care neurological institute: A hospital-based brain tumor registry. Neurology India. 2016;64(3):494.
Mohammed A, Hamdan A, Homoud A. Histopathological profile of brain tumors: a 12-year retrospective study from Madinah, Saudi Arabia. Asian Journal of Neurosurgery. 2019;14(04):1106-11.
Rajendran J, Krishnanswamy R. Histomorphological spectrum of pediatric supratentorial CNS tumors: A 3-year retrospective study in a tertiary care center. Journal of Pediatric Neurosciences. 2021;16(3):199.
- Abstract Viewed: 92 times
- PDF Downloaded: 42 times